Journal of Neuroimmunology
Volume 227, Issue 1 , Pages 185-189 , 8 October 2010

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study

  • Bassem Yamout

      Affiliations

    • Departments of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    • Corresponding Author InformationCorresponding author. Multiple Sclerosis Clinic and Research Center, Doctors' Center, 3rd Floor, Cairo St, near AUH, Beirut, Lebanon. Tel.: +961 1 344042; fax: +961 1 751517.
    • ,
  • Roula Hourani

      Affiliations

    • Departments of Radiology, American University of Beirut Medical Center, Beirut, Lebanon
    • ,
  • Haytham Salti

      Affiliations

    • Departments of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon
    • ,
  • Wissam Barada

      Affiliations

    • Departments of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    • Current Address: Department of Internal Medicine at International Medical Center in Jeddah, KSA.
    • ,
  • Taghrid El-Hajj

      Affiliations

    • Departments of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    • Current Address: Department of Internal Medicine at Al Rasoul Hospital, Beirut, Lebanon.
    • ,
  • Aghiad Al-Kutoubi

      Affiliations

    • Departments of Radiology, American University of Beirut Medical Center, Beirut, Lebanon
    • ,
  • Aline Herlopian

      Affiliations

    • Departments of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    • ,
  • Elizabeth Kfoury Baz

      Affiliations

    • Departments of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    • ,
  • Rami Mahfouz

      Affiliations

    • Departments of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    • ,
  • Rima Khalil-Hamdan

      Affiliations

    • Departments of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    • ,
  • Nabeela M.A. Kreidieh

      Affiliations

    • Departments of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
    • ,
  • Marwan El-Sabban

      Affiliations

    • Departments of Human Morphology, American University of Beirut Medical Center, Beirut, Lebanon
    • ,
  • Ali Bazarbachi

      Affiliations

    • Departments of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

Received 10 May 2010 ,Revised 12 July 2010 ,Accepted 19 July 2010.

References 

  1. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J. Med. 2006;355(12):1222–1232
  2. Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. 2009;57:1192–1203
  3. Caroll WM. Oral therapy for multiple sclerosis — sea change or incremental step?. N Engl J. Med. 2010;362:456–458
  4. Couri CE, Foss MC, Voltarelli JC. Secondary prevention of type one diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration. Braz. J. Med. Biol. Res. 2006;39(10):1271–1280
  5. Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H, et al. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mult. Scler. 2010;16(4):503–510
  6. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 2007;61:219–227
  7. Gordon D, Pavlovska G, Glover C, Uney J, Wraith D, Scolding N. Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Neurosci. Lett. 2008;448:71–73
  8. Grigoriadis N. Interferon-β treatment in relapsing-remitting multiple sclerosis. A review. Clin. Neurol. Neurosurg. 2002;104:251–258
  9. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, et al. Transplantability and therapeutic effects of bone-marrow derived mesenchymal cells in children with osteogenesis imperfect. Nat. Med. 1999;5:309–313
  10. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfect. Blood. 2001;97:1227–1231
  11. Karussis D, Kassis I. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience. Clin. Neurol. Neurosurg. 2008;110:889–896
  12. Karussis D, Kassis I, BG Kurkalli S, Slavin S. Immunomudolation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J. Neurol. Sci. 2008;265:131–135
  13. Kassis I, Grigoriadis N, Kurkalli BG, Mizrachi-Kol R, Ben-Hur T, Slavin S, et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch. Neurol. 2008;65:754–761
  14. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogenic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler Syndrome (MPS-IH). BMT. 2002;30:215–222
  15. Krampera M, Pasini A, Pizzolo G, Cosmi L, Romagnani S, Annunziato F. Rgenerative and immunomodulatory potential of mesenchymal stem cells. Curr. Opin. Pharmacol. 2006;6:435–441
  16. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J. Med. 2006;355(12):1199–1209
  17. Martino G, Franklin RJ, Van Evercooren AB, Kerr DA. Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat. Rev. Neurol. 2010;6:247–255
  18. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Boccaletti R, et al. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol. Res. 2006;28:523–526
  19. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. J. Exp. Neurol. 2010;223(1):229–237
  20. Murray TJ. The history of multiple sclerosis: the changing frame of the disease over the centuries. J. Neurol. Sci. 2009;277:3–8(Supp 1)
  21. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka M, Schmidbauer M, Laursen H, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006;129:3165–3172
  22. Payne N, Siatskas C, Bernard C. The promise of stem cell and regenerative therapies for multiple sclerosis. J. Autoimmun. 2008;31:288–294
  23. Phinney DG, Kopen G, Righter W, Webster S, Tremain N, Prockop DJ. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J. Cell. Biochem. 1999;75:424–436
  24. Pluchino S, Zanotti L, Brini E, Ferrari S, Martino G. Regeneration and repair in multiple sclerosis: the role of cell transplanation. Neurosci. Lett. 2009;456:101–106
  25. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria of multiple sclerosis: 2005 revision to the McDonald criteria. Ann. Neurol. 2005;58:840–846
  26. Schachinger V, Erbs S, Elsasser A, Haberbasch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J. Med. 2006;355(12):1210–1221
  27. Scolding N, Marks D, Rice C. Autologous mesenchymal bone marrow stem cell: practical considerations. J. Neurol. Sci. 2008;265:111–115
  28. Shihabuddin L, Aubert I. Stem cell transplantation for neurometabolic and neurodegenerative diseases. J Neuropharm. 2010;58:845–854
  29. Slavin S, Kurkalli B, Karussis D. The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders. Clin. Neurol. Neurosurg. 2008;110:943–946
  30. Talan J. FDA approves first clinical trials of stem cells for ALS. Neurol. Today. 2009;9:12–13(issue 21)
  31. Uccelli A, Zappia E, Benvenuto F, Frassoni F, Mancardi G. Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. Exp. Opin. Biol. Ther. 2006;6:17–22
  32. Uccelli A, Frassoni F, Mancardi G. Stem cells for multiple sclerosis: promises and reality. Regenerative Med. 2007;2:7–9
  33. Ucelli A, Mancardi G. Stem cell transplantation in multiple sclerosis. Curr. Opin. Neurol. 2010;23:218–225
  34. Vosoughi R, Freedman MS. Therapy of MS. Clin. Neurol. Neurosurg. 2010;112:365–385
  35. Watorek E, Klinger M. Stem cells in nephrology: present status and future. Arch Immunol. Ther. Exp. (Warsz). 2006;54(1):45–50
  36. Wiendl H, Hohlfeld R. Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed success. Neurology. 2009;72:1008–1015
  37. Yang J, Rostami A, Zhang GX. Cellular remyelinating therapy in multiple sclerosis. J. Neurol. Sci. 2009;276:1–5
  38. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood. 2005;106(5):1755–1761
  39. Zhang J, Li Y, Chen J, Cui Y, Lu M, Stanton EB, et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp. Neurol. 2005;195:16–26

☆ This study was funded by intramural grants as well as grants from the “Azem and Saadeh” non-profit Lebanese organization. The university provided the equipment which is part of their property.

PII: S0165-5728(10)00326-7

doi: 10.1016/j.jneuroim.2010.07.013

Journal of Neuroimmunology
Volume 227, Issue 1 , Pages 185-189 , 8 October 2010

Article Tools

* Image Usage & Resolution